Compound index

Incretin & Metabolic Receptor Agonists

Semaglutide

Also known as Ozempic · Wegovy · Rybelsus

FDA-approved for specific indicationsFDA-approved

Last reviewed: 2026-11-19

History

Novo Nordisk researchers including Jesper Lau and colleagues published its discovery in 2015; initial FDA approval followed in 2017.

Key sources

Targeted factual corrections checked against the sources below on November 19, 2026. This is not an exhaustive systematic review; discovery dates, exact molecular forms and current labels require separate verification.

Related compounds

  • Retatrutide

    Same scientific class · A 39-amino-acid chain. · Late-stage human trials

  • Tirzepatide

    Same scientific class · A 39-amino-acid chain. · FDA-approved for specific indications

Related glossary terms